div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: 116Concomitant to these initial safety studies the efficacy of PTC 124 was tested in mouse models including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation src=https:reader036fdocumentsinreader036viewer20220711085fe26df086bb8b0c585469a8html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divp- 116 -pdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: 116Concomitant to these initial safety studies the efficacy of PTC 124 was tested in mouse models including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation src=https:reader036fdocumentsinreader036viewer20220711085fe26df086bb8b0c585469a8html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divp- 117 -pdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: 116Concomitant to these initial safety studies the efficacy of PTC 124 was tested in mouse models including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation src=https:reader036fdocumentsinreader036viewer20220711085fe26df086bb8b0c585469a8html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divp- 118 -pdivdiv class=trans-pagebuttonPage 4button div class=trans-image amp-img class=trans-thumb alt=Page 4: 116Concomitant to these initial safety studies the efficacy of PTC 124 was tested in mouse models including a model for cystic fibrosis harboring the CFTR-G542X stop codon mutation src=https:reader036fdocumentsinreader036viewer20220711085fe26df086bb8b0c585469a8html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divp- 119 -pdivdiv class=trans-pagebuttonPage 5button div class=trans-image amp-img class=trans-thumb alt=Page 5: 116Concomitant to these initial safety studies the efficacy of PTC 124 was tested in mouse models including a model for cystic...